⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for master protocol

Every month we try and update this database with for master protocol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaNCT03970447
Glioblastoma
Temozolomide
Lomustine
Regorafenib
Radiation
Paxalisib
VAL-083
VT1021
Troriluzole
ADI-PEG 20
18 Years - Global Coalition for Adaptive Research
Umbrella Study for Analysis of Data Related to Patients With CancerNCT06018753
Cancer
- Tempus AI
PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, and Sabestomig in HNSCCNCT06366451
Head and Neck S...
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesNCT04541108
Solid Tumor
Rilvegostomig
Volrustomig
Sabestomig
Pembrolizumab
18 Years - Presage Biosciences
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in AustraliaNCT04891718
Solid Tumour
MVC-101
Nivolumab
MVC-101 + Nivol...
18 Years - Presage Biosciences
PBI-MST-01(NCT04541108) Substudy TAK-02: Intratumoral Microdosing of TAK-676 in HNSCCNCT06062602
Head and Neck S...
TAK-676
Carboplatin
5-FU
Paclitaxel
TAK-676 + Carbo...
Carboplatin + P...
Carboplatin + 5...
TAK-676 + Carbo...
TAK-676 + Carbo...
18 Years - Presage Biosciences
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)NCT03527147
NHL
DLBCL
Non-hodgkin's L...
Diffuse Large B...
AZD9150
Acalabrutinib
AZD6738
Hu5F9-G4
Rituximab
AZD5153
18 Years - 130 YearsAcerta Pharma BV
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: